NDC 62559-631

Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate is a Oral Granule, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Erythromycin Ethylsuccinate.

Product ID62559-631_25635db5-a227-445d-850a-a98c5f4772ff
NDC62559-631
Product TypeHuman Prescription Drug
Proprietary NameErythromycin Ethylsuccinate
Generic NameErythromycin Ethylsuccinate
Dosage FormGranule, For Suspension
Route of AdministrationORAL
Marketing Start Date2019-03-25
Marketing CategoryANDA / ANDA
Application NumberANDA062055
Labeler NameANI Pharmaceuticals, Inc.
Substance NameERYTHROMYCIN ETHYLSUCCINATE
Active Ingredient Strength400 mg/5mL
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62559-631-01

100 mL in 1 BOTTLE (62559-631-01)
Marketing Start Date2019-03-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62559-631-01 [62559063101]

Erythromycin Ethylsuccinate GRANULE, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA062055
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-03-25

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL

OpenFDA Data

SPL SET ID:3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 686418
  • 686400
  • UPC Code
  • 0362559631013
  • 0362559630016
  • Pharmacological Class

    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]
    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]

    NDC Crossover Matching brand name "Erythromycin Ethylsuccinate" or generic name "Erythromycin Ethylsuccinate"

    NDCBrand NameGeneric Name
    0254-1020Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    0254-1021Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    24338-110ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-130ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-132ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-134Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    52536-136Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-440Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-630Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-631Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    63629-2500Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    69238-1503Erythromycin EthylsuccinateErythromycin
    69238-1504Erythromycin EthylsuccinateErythromycin
    71209-102Erythromycin ethylsuccinateErythromycin ethylsuccinate
    71209-103Erythromycin ethylsuccinateErythromycin ethylsuccinate
    24338-100E.E.SErythromycin Ethylsuccinate
    24338-134E.E.SErythromycin Ethylsuccinate
    24338-136E.E.SErythromycin Ethylsuccinate
    24338-130Ery-PedErythromycin Ethylsuccinate
    24338-132Ery-PedErythromycin Ethylsuccinate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.